Change in Boardroom
| NOVA PHARMA SOLUTIONS BERHAD |
| Date of change | 01 Jul 2020 |
| Name | MR NG TIK HWA |
| Age | 52 |
| Gender | Male |
| Nationality | Malaysia |
| Designation | Independent Director |
| Directorate | Independent and Non Executive |
| Type of change | Appointment |
Qualifications
| No | Qualifications |
Major/Field of Study |
Institute/University |
Additional Information |
|
Degree
|
B.Sc Chemical Engineering |
University of Technology, Malaysia (UTM) |
|
| Working experience and occupation | Mr Ng Tik Hwa ("Allan") is currently the General Manager/Site Director of Haemonetics Malaysia Sdn Bhd, a company which is involved in manufacturing of whole blood devices and apheresis devices.He is the pioneer who was involved in the set-up of the company in 2013.
Prior to this, Allan was attached with Edward Life Sciences (Singapore) Pte. Ltd. as the Director of Manufacturing based in Singapore for two years. The company is involved in the core business of producing tissue heart valve.
Allan started his career as a Process Engineer at MediQuip Sdn Bhd and was with the company for 20 years. His last position held in the company was the Plant Manager for its medical device manufacturing plant. He carries with him about 28 years of experience in medical device manufacturing and operations. |
| Directorships in public companies and listed issuers (if any) | Nil |
| Family relationship with any director and/or major shareholder of the listed issuer | Nil |
| Any conflict of interests that he/she has with the listed issuer | Nil |
| Details of any interest in the securities of the listed issuer or its subsidiaries | Nil |
Announcement Info
| Company Name | NOVA PHARMA SOLUTIONS BERHAD |
| Stock Name | NPS |
| Date Announced | 01 Jul 2020 |
| Category | Change in Boardroom |
| Reference Number | C03-23062020-00003 |